Deutsche Bank’s LENZ Therapeutics LENZ Stock Holding History

Deutsche Bank’s Portfolio LENZ Stock Details LENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$92.5K	Buy	16,290 +1,010	+7%	+$8.14K	﹤0.01%	3495
2026 Q1	$140K	Buy	15,280 +1,469	+11%	+$20.6K	﹤0.01%	3137
2025 Q4	$221K	Buy	13,811 +352	+3%	+$10.3K	﹤0.01%	2967
2025 Q3	$627K	Buy	13,459 +1,595	+13%	+$58.6K	﹤0.01%	2435
2025 Q2	$348K	Buy	11,864 +2,398	+25%	+$65.2K	﹤0.01%	2646
2025 Q1	$243K	Sell	9,466 -257	-3%	-$6.33K	﹤0.01%	2866
2024 Q4	$281K	Buy	9,723 +4,370	+82%	+$133K	﹤0.01%	2948
2024 Q3	$127K	Buy	5,353 +60	+1%	+$1.33K	﹤0.01%	3137
2024 Q2	$91.5K	Buy	+5,293	New	+$92.5K	﹤0.01%	3148
2022 Q2	–	Sell	-2,363	Closed	-$84K	–	4354
2022 Q1	$84K	Buy	2,363 +955	+68%	+$59.7K	﹤0.01%	3640
2021 Q4	$123K	Buy	1,408 +73	+5%	+$6.05K	﹤0.01%	3616
2021 Q3	$153K	Buy	+1,335	New	+$198K	﹤0.01%	3702

Other funds holding LENZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.15B AUM 13.14% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

KBC Group Brussels, Belgium $46.3B AUM 43.9% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return

SOADOR

State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return

KFA

Kelleher Financial Advisors New York $705M AUM 16.14% 1-Year Est. Return

Deutsche Bank's LENZ Position: Q2 2026 in Review

Deutsche Bank increased its LENZ Therapeutics (LENZ) stake by 6.6% in Q2 2026, buying an estimated $8.14K and bringing the position to 16,290 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3495.

Deutsche Bank first reported a position in LENZ in Q3 2021 and has held it in 12 quarters since. The position peaked at $627K in Q3 2025. 41 funds tracked by Wall St. Rank hold LENZ as of Q2 2026.

Deutsche Bank held 16,290 shares of LENZ Therapeutics worth $92.5K as of Q2 2026.
Deutsche Bank bought 1,010 LENZ Therapeutics shares in Q2 2026, an estimated $8.14K.
LENZ Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3495 holding.
Deutsche Bank first reported a position in LENZ Therapeutics in Q3 2021 and has held it in 12 quarters since.
Deutsche Bank's LENZ Therapeutics position peaked at $627K in Q3 2025.
41 funds tracked by Wall St. Rank held LENZ Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.